Monte Rosa Therapeutics had a revenue of 9.22M in the quarter ending Sep 30, 2024, with 96.29%. This bring the company's revenue in the last twelve months to 23.73M, Decreased 63.51%. In the fiscal year ending Dec 31, 2023, Monte Rosa Therapeutics had annual revenue of 0.00 with ― growth.